Charles River Laboratories International Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Charles River Laboratories International Inc 公司

Charles River Laboratories International, Inc. 提供基本產品和服務，幫助全球製藥和生物技術公司、政府機構和學術機構加速其研究和藥物開發工作。該公司的研究模型和服務部門由三項業務組成，提供基礎工具，使其客戶能夠發現新分子：研究模型、研究模型服務和細胞解決方案。其發現和安全評估部門提供受監管和非受監管的 DSA 服務，以支持潛在新藥的研究、開發和監管要求的安全測試，包括治療發現和優化以及體外和體內研究、實驗室支持服務以及戰略非臨牀諮詢和項目管理，以支持產品開發。其製造解決方案部門包括微生物解決方案和生物製劑解決方案。

Charles River Laboratories International Inc簡介



公司代碼CRL

公司名稱Charles River Laboratories International Inc

上市日期Jun 23, 2000

CEOMr James C. Foster

員工數量18600

證券類型Ordinary Share

年結日Jun 23

公司地址251 Ballardvale St

城市WILMINGTON

上市交易所NYSE Consolidated

國家United States of America

郵編01887

電話17812226000

網址https://www.criver.com/

公司代碼CRL

上市日期Jun 23, 2000

CEOMr James C. Foster

Charles River Laboratories International Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

12.48K

-8.77%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

Dr. Nancy C. Andrews, M.D., Ph.D.

Independent Director

3.96K

+31.35%

Ms. Reshema Kemps-Polanco

Independent Director

2.59K

+155.42%

Dr. Craig B. Thompson, M.D.

Independent Director

2.41K

+64.49%

Mr. Abraham N. (Abe) Ceesay

Independent Director

946.00

--

名稱

名稱/職務

職務

持股

持股變動

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

12.48K

-8.77%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

業務USD

名稱

營收

佔比

DSA

618.03M

59.88%

RMS

213.27M

20.66%

Manufacturing

200.84M

19.46%

地區USD

名稱

營收

佔比

United States

549.86M

53.27%

Europe

281.86M

27.31%

Canada

135.59M

13.14%

Asia Pacific (Region)

54.50M

5.28%

Other

10.33M

1.00%

業務

地區

業務USD

名稱

營收

佔比

DSA

618.03M

59.88%

RMS

213.27M

20.66%

Manufacturing

200.84M

19.46%

股東統計

更新時間: 10月8日週三

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

11.79%

Wellington Management Company, LLP

7.66%

BlackRock Institutional Trust Company, N.A.

5.59%

Allspring Global Investments, LLC

4.43%

State Street Investment Management (US)

3.78%

其他

66.77%

持股股東

佔比

The Vanguard Group, Inc.

11.79%

Wellington Management Company, LLP

7.66%

BlackRock Institutional Trust Company, N.A.

5.59%

Allspring Global Investments, LLC

4.43%

State Street Investment Management (US)

3.78%

其他

66.77%

股東類型

持股股東

佔比

Investment Advisor

43.53%

Investment Advisor/Hedge Fund

41.31%

Hedge Fund

9.40%

Research Firm

5.95%

Bank and Trust

2.19%

Pension Fund

1.50%

Individual Investor

1.05%

Sovereign Wealth Fund

1.04%

Private Equity

0.20%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

1366

51.65M

104.95%

-10.83M

2025Q2

1399

56.14M

114.06%

-4.38M

2025Q1

1435

55.38M

112.72%

-5.93M

2024Q4

1423

54.85M

107.26%

-4.35M

2024Q3

1392

53.78M

105.14%

-5.12M

2024Q2

1399

54.00M

104.84%

-4.00M

2024Q1

1393

53.76M

104.37%

-4.04M

2023Q4

1424

53.56M

104.42%

-4.24M

2023Q3

1446

53.56M

104.42%

-3.98M

2023Q2

1427

52.88M

103.32%

-3.95M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

5.80M

11.79%

-293.30K

-4.81%

Jun 30, 2025

Wellington Management Company, LLP

3.77M

7.66%

-517.21K

-12.07%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.75M

5.59%

-156.85K

-5.39%

Jun 30, 2025

Allspring Global Investments, LLC

2.29M

4.66%

+516.52K

+29.11%

Jun 30, 2025

State Street Investment Management (US)

1.86M

3.78%

-43.84K

-2.30%

Jun 30, 2025

Nomura Securities Co., Ltd.

1.57M

3.19%

+967.65K

+160.84%

Jun 30, 2025

Ariel Investments, LLC

1.42M

2.88%

+314.57K

+28.58%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.23M

2.5%

-31.43K

-2.49%

Jun 30, 2025

Harris Associates L.P.

1.16M

2.36%

+1.16M

--

Jun 30, 2025

Invesco Capital Management LLC

1.09M

2.22%

+110.27K

+11.23%

Jun 30, 2025

持股ETF



更新時間: 10月6日週一

機構名稱

佔比

First Trust NASDAQ Pharmaceuticals ETF

2.13%

Invesco S&P 500 Equal Weight Health Care ETF

1.78%

VanEck Biotech ETF

1.62%

Schwab Ariel Opportunities ETF

1.61%

ROBO Global Healthcare Technology & Innovation ETF

1.56%

Franklin Genomic Advancements ETF

1.37%

iShares Health Innovation Active ETF

1.29%

Principal Quality ETF

1.01%

WisdomTree US Value Fund

0.98%

Invesco S&P 500 High Beta ETF

0.93%

First Trust NASDAQ Pharmaceuticals ETF

佔比2.13%

Invesco S&P 500 Equal Weight Health Care ETF

佔比1.78%

VanEck Biotech ETF

佔比1.62%

Schwab Ariel Opportunities ETF

佔比1.61%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.56%

Franklin Genomic Advancements ETF

佔比1.37%

iShares Health Innovation Active ETF

佔比1.29%

Principal Quality ETF

佔比1.01%

WisdomTree US Value Fund

佔比0.98%

Invesco S&P 500 High Beta ETF

佔比0.93%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據